LPAR2 and amyotrophic lateral sclerosis: In the search for the mechanisms underlying the harmful actions of LPA2 at the early stages of ALS disease, we revealed this receptor did not promote spinal cord gliosis, motoneuron death, motor axon demyelination, but it increased muscle atrophy and inflammation.